These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1208826)

  • 21. On the problem of the characterization of late effects by a linear-quadratic survival function. II. Some clinical applications.
    Ulmer W
    Strahlenther Onkol; 1988 Sep; 164(9):553-9. PubMed ID: 3175855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development and utilization of the Nominal Standard Dose for the tolerance dosage to healthy tissue in radiotherapy].
    Gabriel-Jürgens P; Gremmel H; Wendhausen H
    Strahlentherapie; 1976 Feb; 151(2):99-112. PubMed ID: 1258089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evaluation of low dose hyper-radiosensitivity in normal human skin.
    Harney J; Shah N; Short S; Daley F; Groom N; Wilson GD; Joiner MC; Saunders MI
    Radiother Oncol; 2004 Mar; 70(3):319-29. PubMed ID: 15064019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and radiobiologic evaluation of radiation dosage in radiotherapy of vaginal cancer].
    Kanaev SV; Turkevich VG
    Vopr Onkol; 1996; 42(6):44-7. PubMed ID: 9123901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How tolerant are partial dose values? Some additional remarks on the concept of a tolerance dose].
    Jensen JM; Melchert UH; Ihnen E
    Strahlenther Onkol; 1992 Nov; 168(11):640-5. PubMed ID: 1455292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Critical evaluation of the conception of nominal standard dose].
    Kholin VV
    Med Radiol (Mosk); 1976 Jan; 21(1):55-65. PubMed ID: 933736
    [No Abstract]   [Full Text] [Related]  

  • 29. Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors.
    Landthaler M; Hagspiel HJ; Braun-Falco O
    Arch Dermatol; 1995 Feb; 131(2):182-6. PubMed ID: 7857115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation into the clinical effects of fast neutrons. Methods and early observations.
    Catterall M; Rogers C; Thomlinson RH; Field SB
    Br J Radiol; 1971 Aug; 44(524):603-11. PubMed ID: 4997649
    [No Abstract]   [Full Text] [Related]  

  • 31. Importance of tumor size and repopulation for radiocurability of skin cancer.
    Maciejewski BA; Skates S; Zajusz A; Lange D
    Neoplasma; 1993; 40(1):51-4. PubMed ID: 8350948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of time-dose-fractionation models in planning the radiation treatment of malignant tumors].
    Pavlov AS; Kostromina KN; Datsenko VS; Fadeeva MA; Bocharov AL
    Med Radiol (Mosk); 1983 Mar; 28(3):80-3. PubMed ID: 6835063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frequency of skin cancer recurrences after radiation therapy].
    Skoropad IuD
    Med Radiol (Mosk); 1980 Aug; 25(8):75-8. PubMed ID: 6995781
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental dosage with lineal sources of Ir 192. Analysis and evaluation of errors in the treatment of cutaneous neoplastic lesions by means of interstitial curitherapy].
    Olivares MP; Pérez Vázquez JM; Blanco Mangudo MS; Pérez Modrego S
    Acta Oncol (Madr); 1976; 11(2):169-86. PubMed ID: 797224
    [No Abstract]   [Full Text] [Related]  

  • 35. [Radiobiological analysis of cancer curability depending on the radiotherapy dosage and its timely distribution based on the example of skin cancer].
    Kholin VV; Frolova ZV
    Med Radiol (Mosk); 1975 Apr; 20(4):37-45. PubMed ID: 1196028
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased breast cancer risk after radiotherapy for acne among women with skin cancer.
    El-Gamal H; Bennett RG
    J Am Acad Dermatol; 2006 Dec; 55(6):981-9. PubMed ID: 17097395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of conventionally fractionated radiotherapy in the local treatment of HIV-related Kaposi's sarcoma].
    Saran F; Adamietz IA; Mose S; Thilmann C; Böttcher HD
    Strahlenther Onkol; 1995 Oct; 171(10):594-9. PubMed ID: 8571179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nominal standard dose and the ret.
    Ellis F
    Br J Radiol; 1971 Feb; 44(518):101-8. PubMed ID: 5548787
    [No Abstract]   [Full Text] [Related]  

  • 39. [The surface dosage in the radiotherapy of a small breast carcinoma with 6-MV x-rays. A contribution to quality assurance in radiotherapy].
    Müller-Sievers K; Kober B; Semrau C
    Strahlenther Onkol; 1992 May; 168(5):291-6. PubMed ID: 1598665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
    Röper B; Kaisig D; Auer F; Mergen E; Molls M
    Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.